Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonance

被引:14
作者
Fabregat-Safont, David [1 ]
Carbon, Xoan [2 ]
Gil, Cristina [2 ]
Ventura, Mireia [2 ]
Sancho, Juan V. [1 ]
Hernandez, Felix [1 ]
Ibanez, Maria [1 ]
机构
[1] Univ Jaume 1, Res Inst Pesticides & Water, Avda Sos Baynat S-N, Castellon de La Plana 12071, Spain
[2] Energy Control Asociac Bienestar & Desarrollo, C Independencia 384, Barcelona 08041, Spain
关键词
5-PPDI; Synthetic cathinones; 1-(2,3-Dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-one; High-resolution mass spectrometry; NMR spectroscopy; FTIR spectroscopy; PSYCHOACTIVE SUBSTANCES; DESIGNER DRUGS; BLOTTER PAPERS; ATR-FTIR; IDENTIFICATION; DERIVATIVES; CANNABINOIDS; MS;
D O I
10.1007/s11419-018-0422-0
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In this work, the identification and characterization of the novel synthetic cathinone 5-PPDI found in a suspect drug sample were performed. The suspect sample was analyzed by gas chromatography-mass spectrometry (GC-MS), Fourier-transformed infrared (FTIR) spectroscopy, ultra-high performance liquid chromatography-high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy. The fragmentation observed in GC-MS and the identification of functional groups by FTIR was not enough for compound identification. After an exhaustive analysis of the accurate-mass fragmentation observed in HRMS, the compound was tentatively identified as the novel cathinone 5-PPDI. Finally, five different NMR experiments were used for the unequivocal identification and complete characterization of the compound. In addition, the origin of this cathinone was investigated in depth. The analytical data provided in this work will be useful for the identification of 5-PPDI by forensic laboratories. In addition, the origin of this cathinone has been investigated, which could be of interest for the identification of future synthetic cathinones prepared following the similar synthesis route.
引用
收藏
页码:447 / 457
页数:11
相关论文
共 27 条
  • [1] Analytical characterization of three cathinone derivatives, 4-MPD, 4F-PHP and bk-EPDP, purchased as bulk powder from online vendors
    Apirakkan, Orapan
    Frinculescu, Anca
    Shine, Trevor
    Parkin, Mark C.
    Cilibrizzi, Agostino
    Frascione, Nunzianda
    Abbate, Vincenzo
    [J]. DRUG TESTING AND ANALYSIS, 2018, 10 (02) : 372 - 378
  • [2] The new drug phenomenon
    Brandt, Simon D.
    King, Leslie A.
    Evans-Brown, Michael
    [J]. DRUG TESTING AND ANALYSIS, 2014, 6 (7-8) : 587 - 597
  • [3] Casale J.F., 2012, MICROGRAM J, V9, P33
  • [4] Department of justice. Drug Enforcement Administration (DEA), 2014, SCHED CONTR SUBST TE
  • [5] European Monitoring Centre for Drugs and Drug Addiction, 2017, EMCDDA EUR JT PUBL, P88, DOI [10.2810/88175, DOI 10.2810/88175]
  • [6] Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino) cyclohexyl)-N-methylbenzamide (U-49900)
    Fabregat-Safont, D.
    Carbon, X.
    Ventura, M.
    Fornis, I.
    Guillamon, E.
    Sancho, J. V.
    Hernandez, F.
    Ibanez, M.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [7] Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain
    Fabregat-Safont, D.
    Fornis, I.
    Ventura, M.
    Gil, C.
    Calzada, N.
    Sancho, J. V.
    Hernandez, F.
    Ibanez, M.
    [J]. DRUG TESTING AND ANALYSIS, 2017, 9 (07) : 1073 - 1080
  • [8] Flashback, 2015, NY RC 5 PPDI NAG INF
  • [9] Identification of substituted cathinones: 3,4-Methylenedioxy derivatives by high performance liquid chromatography-quadrupole time of flight mass spectrometry
    Fornal, Emilia
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 81-82 : 13 - 19
  • [10] Consumption of new psychoactive substances in a Spanish sample of research chemical users
    Gonzalez, Debora
    Ventura, Mireia
    Caudevilla, Fernando
    Torrens, Marta
    Farre, Magi
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (04) : 332 - 340